ABT vs OSUR
ABT: A diversified global healthcare leader focused on life-changing technologies across medical devices, diagnostics, nutrition, and branded pharmaceuticals. OSUR: OraSure Technologies is a medical diagnostic company dedicated to decentralizing healthcare through rapid, accessible, and point-of-care testing and specimen collection tools.
Side-by-side fundamentals
| Metric | ABT | OSUR | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $100.51 | $3.86 | |
| Market cap | $173.9B | $266M | |
| P/E as of 2026-10-21 | 28.15 | n/a | |
| Net margin FY2025, SEC XBRL | +14.7% | -59.8% | ABT higher |
| Gross margin FY2025, SEC XBRL | n/a | +41.9% | |
| Operating margin FY2025, SEC XBRL | +18.2% | -62.6% | ABT higher |
| ROE FY2025, SEC XBRL | +12.4% | -20.2% | ABT higher |
| ROA FY2025, SEC XBRL | +7.5% | -17.0% | ABT higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-03-31 | 0.65 | n/a | |
| Revenue growth (YoY) FY2025, SEC XBRL | +5.7% | -38.1% | ABT higher |
| Revenue CAGR (3y) SEC XBRL | +0.5% | -33.3% | ABT higher |
| Dividend yield as of 2026-09-03 | +2.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 4 | 0 | ABT higher |
| Beta as of 2026-09-03 | 0.18 | 1.08 | |
| 1-year return as of 2026-10-21 close | -21.2% | +30.0% | OSUR higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.